DDG · Class II · 21 CFR 866.5880

FDA Product Code DDG: Transferrin, Antigen, Antiserum, Control

Leading manufacturers include Beckman Coulter, Inc..

48
Total
48
Cleared
97d
Avg days
1977
Since
Growing category - 1 submissions in the last 2 years vs 0 in the prior period
Consistent review times: 84d avg (recent)

FDA 510(k) Cleared Transferrin, Antigen, Antiserum, Control Devices (Product Code DDG)

48 devices
1–24 of 48

About Product Code DDG - Regulatory Context

510(k) Submission Activity

48 total 510(k) submissions under product code DDG since 1977, with 48 receiving FDA clearance (average review time: 97 days).

Submission volume has increased in recent years - 1 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

FDA review times for DDG submissions have been consistent, averaging 84 days recently vs 98 days historically.

DDG devices are reviewed by the Immunology panel. Browse all Immunology devices →